Recombinant GBA Monoclonal Antibody

SKU: AN301962L

Size::50μL

Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Monoclonal Antibodies;Recombinant Antibodies

Abbreviation:GBA

Target Synonym:GBA;GBA1;GCB;GLUC;GC;9-O-sialyl GD3;7-O-sialyl GD3;ACID;acid (includes glucosylceramidase);beta;Acid beta glucosidase;Acid beta-glucosidase;Alglucerase;Beta glucocerebrosidase;BETA GLUCOSIDASE;betaGC;Beta-glucocerebrosidase;D glucosyl N acylsphingosine glucohydrolase;D-glucosyl-N-acylsphingosine glucohydrolase;EC 3.2.1.45;Gba protein;GCase;GLCM;Glucocerebrosidase;Glucocerebrosidase (alt.);GLUCOCEREBROSIDASE PSEUDOGENE;Glucosidase;Glucosidase beta;Glucosylceramidase;Imiglucerase;Lysosomal glucocerebrosidase;OTTHUMP00000033992;OTTHUMP00000033993

Research Areas:Neuroscience;Signal Transduction;Cancer;Metabolism

Conjugation:Unconjugated

Host:Rabbit

Species reactivity:Human;Rat;Mouse

Application:WB;IHC

Isotype:IgG,κ

Clonality:Monoclonal;Recombinant

Clone NO.:A678

UNIProt ID:P04062

Accession:

Background:Beta-Glucosylceramidase (β-GC) is a lysosomal enzyme that catalyzes the hydrolysis of glucocerebroside into free ceramide and glucose. Lysosomal breakdown of glucocerebroside is required for cellular metabolism of complex lipids and proper turnover of cellular membrane. In the absence of GBA, the gene that encodes β-GC, autophagic lysosome reformation is altered, suggesting that β-GC activity is critical to maintain functional lysosomes. The cellular function of lysosomes is to degrade and recycle cellular waste to maintain proper cellular energy metabolism. Mutations in human GBA cause deficiency in β-GC, resulting in the accumulation of lysosomal glucocerebroside. Macrophages are particularly sensitive to lysosomal glucocerebroside accumulation due to their role in phagocytosis-mediated breakdown of cellular debris and dying cells. Gaucher disease, a rare autosomal recessive lysosomal storage disorder that is genetically linked to GBA, is marked by engorged “Gaucher cell” macrophages in the spleen, liver, and bone marrow. GBA mutations are the most common genetic risk factor for Parkinson’s disease (PD), a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra with formation of α-synuclein-rich Lewy bodies in surviving neurons. GBA mutations may play a direct role in accumulation of α-synuclein by mechanisms that are poorly understood, but may include mislocalization of lysosomal β-GC causing impaired lysosomal degradation of α-synuclein.

Concentration:1 mg/mL

Immunogen:Recombinant human GBA fragment

Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

Purification method:Protein A purified

Dilution:WB 1:1000-1:20000;IHC 1:50

Calculated MW:60 kDa

ObservedMW:60 kDa